accountprofit increased 7.2%, as sales and margins showed modest improvement. Shares rose 2.7%. In deal activity, Cardinal Health said it will buy privately held pharmaceutical distributor Kinray for $1.3 billion. Cardinal Health, the second-biggest drug...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Blue Chips Gain Strength
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account